574 related articles for article (PubMed ID: 24370016)
21. Pattern associated leukemia immunophenotypes and measurable disease detection in acute myeloid leukemia or myelodysplastic syndrome with mutated NPM1.
Zhou Y; Moon A; Hoyle E; Fromm JR; Chen X; Soma L; Salipante SJ; Wood BL; Wu D
Cytometry B Clin Cytom; 2019 Jan; 96(1):67-72. PubMed ID: 30417521
[TBL] [Abstract][Full Text] [Related]
22. AML with mutated NPM1 carrying a normal or aberrant karyotype show overlapping biologic, pathologic, immunophenotypic, and prognostic features.
Haferlach C; Mecucci C; Schnittger S; Kohlmann A; Mancini M; Cuneo A; Testoni N; Rege-Cambrin G; Santucci A; Vignetti M; Fazi P; Martelli MP; Haferlach T; Falini B
Blood; 2009 Oct; 114(14):3024-32. PubMed ID: 19429869
[TBL] [Abstract][Full Text] [Related]
23. The surface molecular signature of leukemic cells is associated with NPM1 mutations and FLT3 -ITD in patients with de novo acute myeloid leukemia.
Su L; Gao SJ; Li W; Tan YH; Cui JW; Han W
Acta Haematol; 2014; 131(3):148-52. PubMed ID: 24192815
[TBL] [Abstract][Full Text] [Related]
24. Prognostic factors in normal karyotype acute myeloid leukemia in the absence of the FLT3-ITD mutation.
Jiang A; Jiang H; Brandwein J; Kamel-Reid S; Chang H
Leuk Res; 2011 Apr; 35(4):492-8. PubMed ID: 20684989
[TBL] [Abstract][Full Text] [Related]
25. [The immunophenotypic analysis of CD7+ and (or) CD56+ acute myeloid leukemic stem cells and its applications in minimal residual disease detection].
Cao H; Wang YZ; Wu HH; Chang Y; Hao L; Chen SS; Huang XJ; Lu DP; Liu YR
Zhonghua Xue Ye Xue Za Zhi; 2008 Jan; 29(1):23-8. PubMed ID: 18512311
[TBL] [Abstract][Full Text] [Related]
26. Overexpressed WT1 exhibits a specific immunophenotype in intermediate and poor cytogenetic risk acute myeloid leukemia.
Wang XR; Chang Y; Yuan XY; Wang YZ; Qin YZ; Ruan GR; Lai YY; Liu YR
Ann Hematol; 2020 Feb; 99(2):215-221. PubMed ID: 31900500
[TBL] [Abstract][Full Text] [Related]
27. [Immunophenotypic features in 143 cases of acute promyelocytic leukemia].
Sun HM; Qian SX; Wu YJ; Qiao C; Hong M; Fan L; Yang H; Zhang JF; Zhang SJ; Wu HX; Qiu HX; Lu H; Xu W; Sheng RL; Li JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):176-9. PubMed ID: 19236773
[TBL] [Abstract][Full Text] [Related]
28. Age-dependent frequencies of NPM1 mutations and FLT3-ITD in patients with normal karyotype AML (NK-AML).
Schneider F; Hoster E; Schneider S; Dufour A; Benthaus T; Kakadia PM; Bohlander SK; Braess J; Heinecke A; Sauerland MC; Berdel WE; Buechner T; Woermann BJ; Feuring-Buske M; Buske C; Creutzig U; Thiede C; Zwaan MC; van den Heuvel-Eibrink MM; Reinhardt D; Hiddemann W; Spiekermann K
Ann Hematol; 2012 Jan; 91(1):9-18. PubMed ID: 21744003
[TBL] [Abstract][Full Text] [Related]
29. [Immunophenotypic features of acute myeloid leukemia with AML-1/ETO fusion gene].
Zhang JJ; DU X; Huang ZX; Su JH; Zhou MH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):378-81. PubMed ID: 17493351
[TBL] [Abstract][Full Text] [Related]
30. [Characteristics of 11 patients with acute myeloid leukemia accompanied with karyotype aberration t(6;9)].
Lai YY; Li Y; Shi Y; Dang H; He Q; Feng L; Wang Z; Wang XY; Li N; Liu Q; Liu YR; Qin YZ; Shi HX; Huang XJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1293-6. PubMed ID: 23257419
[TBL] [Abstract][Full Text] [Related]
31. Prognostic impact of Wilms tumor gene mutations in Egyptian patients with acute myeloid leukemia with normal karyotype.
Zidan MA; Kamal Shaaban HM; Elghannam DM
Hematology; 2014 Jul; 19(5):267-74. PubMed ID: 24074521
[TBL] [Abstract][Full Text] [Related]
32. Immunophenotype distinction between acute promyelocytic leukaemia and CD15- CD34- HLA-DR- acute myeloid leukaemia with nucleophosmin mutations.
Ferrari A; Bussaglia E; Úbeda J; Facchini L; Aventin A; Sierra J; Nomdedéu JF
Hematol Oncol; 2012 Sep; 30(3):109-14. PubMed ID: 21812014
[TBL] [Abstract][Full Text] [Related]
33. [Immunophenotypes, cytogenetics and clinical features of 192 patients with acute myeloid leukemia].
Tong HX; Wang HH; Zhang JH; Liu ZG; Zheng YC; Wang YX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Oct; 17(5):1174-8. PubMed ID: 19840445
[TBL] [Abstract][Full Text] [Related]
34. The predictive value of minimal residual disease when facing the inconsistent results detected by real-time quantitative PCR and flow cytometry in NPM1-mutated acute myeloid leukemia.
Gao MG; Ruan GR; Chang YJ; Liu YR; Qin YZ; Jiang Q; Jiang H; Huang XJ; Zhao XS
Ann Hematol; 2020 Jan; 99(1):73-82. PubMed ID: 31768677
[TBL] [Abstract][Full Text] [Related]
35. Immunologic characteristics and prognosis of myelodysplastic syndrome new subtype: refractory anemia with excess blasts-II.
Wei J; Zhou XF; Zhao F; Zhou JF; Chen Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):111-6. PubMed ID: 19236759
[TBL] [Abstract][Full Text] [Related]
36. Prognostic value of immunophenotyping and gene mutations in elderly patients with acute myeloid leukemia with normal karyotype.
Dang H; Jiang A; Kamel-Reid S; Brandwein J; Chang H
Hum Pathol; 2013 Jan; 44(1):55-61. PubMed ID: 22939316
[TBL] [Abstract][Full Text] [Related]
37. [Immunophenotypic analysis of acute myeloid leukemia with t(8;21)].
Fan L; Wu YJ; Zhang JF; Qiu HR; Qiao C; Wang R; Yang H; Xu W; Li JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1410-3. PubMed ID: 21176340
[TBL] [Abstract][Full Text] [Related]
38. Transplant outcomes of the triple-negative NPM1/FLT3-ITD/CEBPA mutation subgroup are equivalent to those of the favourable ELN risk group, but significantly better than the intermediate-I risk group after allogeneic transplant in normal-karyotype AML.
Ahn JS; Kim HJ; Kim YK; Jung SH; Yang DH; Lee JJ; Kim NY; Choi SH; Jung CW; Jang JH; Kim HJ; Moon JH; Sohn SK; Won JH; Kim SH; Kim DD
Ann Hematol; 2016 Mar; 95(4):625-35. PubMed ID: 26692090
[TBL] [Abstract][Full Text] [Related]
39. The immunophenotype of adult acute myeloid leukemia: high frequency of lymphoid antigen expression and comparison of immunophenotype, French-American-British classification, and karyotypic abnormalities.
Khalidi HS; Medeiros LJ; Chang KL; Brynes RK; Slovak ML; Arber DA
Am J Clin Pathol; 1998 Feb; 109(2):211-20. PubMed ID: 9583894
[TBL] [Abstract][Full Text] [Related]
40. Immunological classification of acute myeloblastic leukemias: relevance to patient outcome.
Casasnovas RO; Slimane FK; Garand R; Faure GC; Campos L; Deneys V; Bernier M; Falkenrodt A; Lecalvez G; Maynadié M; Béné MC
Leukemia; 2003 Mar; 17(3):515-27. PubMed ID: 12646939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]